DMTK stock forecast
Our latest prediction for DermTech, Inc.'s stock price was made on the April 1, 2020 when the stock price was at 10.39$.
In the short term (2weeks), DMTK's stock price should outperform the market by 0.42%. During that period the price should oscillate between -11.01% and +14.52%.
In the medium term (3months), DMTK's stock price should outperform the market by 2.44%. During that period the price should oscillate between -29.95% and +36.05%.Get email alerts
Create a solid portfolio with DMTK
About DermTech, Inc.
DermTech, Inc. is a genomics company in dermatology, which engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate the early detection of skin cancers, assesses inflammatory diseases, and customizes drug treatments. Its products include adhesive skin collection kit, pigmented lesion assay, nevome, and carcinome. The company was founded in 1995 and is headquartered in La Jolla, CA.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -2.81$ per share.
The book value per share is 1.53$
Three months stock forecastApril 1, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|